The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)
Open accessAbstract
Objective The recent increased detection of small-sized peripheral non-small cell lung cancer (NSCLC) has renewed interest in sub-lobar resection in-lieu of lobectomy, the traditional standard of care. CALGB/ALLIANCE 140503 is a multicenter international non-inferiority phase III trial in which NSCLC patients clinically staged as T1aN0 were randomly assigned to lobar or sub-lobar resection. The primary endpoint is disease-free survival. We conducted an exploratory comparative analysis of the perioperative mortality and morbidity associated with both arms of the trial. Patients and Methods Between June 15/2007 and March 13/2017, 697 patients with peripheral NSCLC clinically staged as T1aN0 were intraoperatively randomized (after pathological confirmation of absence of nodal metastases in major hilar and mediastinal nodes) to either lobar (Arm A: 357) or sublobar resection (Arm B: 340; 58% wedge resections). Randomization assignment was based on a stratified permuted-block randomization scheme without concealment. Randomized was stratified according to radiographic tumor size (< 1 cm, 1–1.5 cm, and > 1.5– 2.0 cm), histology (squamous carcinoma, adenocarcinoma and other) and smoking status (never, former, current). The assignment was not concealed. Perioperative mortality was defined as death from any cause within 30 and 90 days of surgical intervention and was calculated on all randomized patients. Morbidity was graded using the Common Terminology Criteria for Adverse Events (CTCAE v4.0). All analyses were done on an intention to treat basis. Results Overall 30 and 90- day mortality for 697 randomized patients were 0.86% (n=6) and 1.4% (n=10). Thirty and 90-day mortality were 1.1% (n=4) and 1.7% (n=6) after lobar resection and 0.6% (n=2) and 1.2% (n=4) after sub-lobar resection yielding a difference between arms of 0.5% (95%CI: −1.1,2.3) and 0.5% (95%CI: −1.5,2.6), respectively, without reaching statistical significance. No complications were observed in 47% of patients (Arm A: 46%, Arm B: 49%). Grade 3/4/5 AEs occurred in 15.2% in Arm A and 14.2% in Arm B. There were no differences between the two arms in cardiac or pulmonary complications. Grade 3 hemorrhage (requiring transfusion) occurred in 6 patients (1.6%) in Arm A and 8 patients (2.3%) in Arm B. Prolonged air leak occurred in 9 patients (2.5%) in Arm A and 2 patients (0.6%) in Arm B. Conclusions In this large, multicenter randomized international trial, post-hoc analysis showed no significant differences in perioperative mortality and morbidity between lobar and sub-lobar resection in physically and functionally fit patients with clinical T1aN0 NSCLC. These data may impact the daily choices made by patients and their physicians in determining the optimal treatment approach for stage I lung cancer. Trial registration This trial is registered as an international standard randomized trial with ClinicalTrials.gov Identifier: NCT00499330 Role of funding source The Cancer Therapy Evaluation Program of the National Cancer Institute (CTEP) approved the trial design
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goldstraw, P., Crowley, J., Chansky, K., Giroux, D. J., Groome, P. A., Rami-Porta, R., Postmus, P. E., Rusch, V., & Sobin, L. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31812f3c1a · Cited by 3,655
Cited by
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
Altorki, N., Wang, X., Kozono, D., Watt, C., Landrenau, R., Wigle, D., Port, J., Jones, D. R., Conti, M., Ashrafi, A. S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212083 · Cited by 1,106
Self-citationA single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer
Suzuki, K., Watanabe, S.-I., Wakabayashi, M., Saji, H., Aokage, K., Moriya, Y., Yoshino, I., Tsuboi, M., Nakamura, S., Nakamura, K., et al. (2022) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.09.146 · Cited by 379
Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies
Succony, L., Rassl, D., Barker, A., McCaughan, F., & Rintoul, R. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102237 · Cited by 342
Metadata
- Authors
- Altorki, N. K., Wang, X., Wigle, D., Gu, L., Darling, G., Ashrafi, A. S., Landrenau, R., Miller, D., Liberman, M., Jones, D. R., Keenan, R., Conti, M., Wright, G., Veit, L. J., Ramalingam, S. S., Kamel, M., Pass, H. I., Mitchell, J. D., Stinchcombe, T., Vokes, E., & Kohman, L. J.
- Venue
- The Lancet Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 6
- Issue
- 12
- Pages
- 915-924
- ISSN
- 2213-2600 (ISSN-L)
- OpenAlex
- W2901122753
- Cited by
- 380
- References
- 1
- FWCI
- 23.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). https://app.cochat.ai/papers/10.1016/s2213-2600(18)30411-9
- The paper
- Altorki, N. K., Wang, X., Wigle, D., Gu, L., Darling, G., Ashrafi, A. S., Landrenau, R., Miller, D., Liberman, M., Jones, D. R., Keenan, R., Conti, M., Wright, G., Veit, L. J., Ramalingam, S. S., Kamel, M., Pass, H. I., Mitchell, J. D., Stinchcombe, T., . . . Kohman, L. J. (2018). Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(18)30411-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.